Marine Pharmaceutical Market, By Source (Marine invertebrates (sponges, corals, tunicates, mollusks), Marine bacteria, Marine macroalgae, Marine microalgae, Marine fungi, Marine sediments/extremophiles, and Marine vertebrates), By Compound Class (Alkaloids, Peptides/Proteins, Polysaccharides, Lipids/Fatty acids, Terpenes/Terpenoids, Sterols, Enzymes, and Secondary metabolites), By Therapeutic Application (Oncology/Anticancer agents, Anti infectives (antibacterial, antiviral, antifungal), Anti inflammatory agents, Cardiovascular drugs, Neuroprotective/neurological drugs, Metabolic disorder drugs, Pain management/analgesics, Dermatological agents, and Immunomodulators), By Development Stage (Discovery/bioprospecting, Preclinical development, Clinical trials, and Approved/Commercialized products), By Formulation Type (Small molecules, Biologics/biopharmaceuticals, Extracts/standardized fractions, and Nutraceutical formulations), By End User (Pharma and Biopharma Companies, Hospitals and Specialty Clinics, CDMOs/CMOs, Nutraceutical/functional food producers, and Academic and research institutes), By Drug Delivery Format (Oral, Injectable/infusion, Topical/dermal, Inhalation, and Implants/controlled release), By Source Habitat (Coastal marine, Deep sea marine, Polar marine, and Hydrothermal vents/extreme environments), By Application Sector (Human therapeutics and Veterinary therapeutics), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Growth Trends and Forecasts (2025-2032)